SRRA Market Cap History



Below is a table of the SRRA market cap history going back to 2/28/2017:

Date SRRA Market Cap
2/28/201778.85M
5/5/201771.09M
8/8/201778.93M
11/6/2017104.07M
2/23/2018156.31M
5/8/2018144.16M
8/7/2018186.60M
11/6/2018126.42M
2/22/2019128.83M
5/6/2019109.79M
8/6/201937.72M
8/2/201920.94M
10/31/201923.15M
1/23/2020137.73M
2/26/2020134.62M
5/5/2020134.00M
8/3/2020124.64M
11/2/2020160.97M
3/8/2021171.40M
5/3/2021237.12M
8/2/2021226.72M
11/1/2021316.91M
3/7/2022702.38M
4/25/20221.33B
5/2/20221.33B

Also see: SRRA Shares Outstanding History
and SRRA YTD Return
SRRA Historical Market Cap:
+72.76% CAGR
SRRA Historical Market Cap: +72.76% CAGR

Mouse over chart for data details
2/28/2017 ...5/2/2022
Sierra Oncology is a late-stage biopharmaceutical company focused on therapies that treat cancer. Co.'s focus is the development and commercialization of momelotinib, an investigational agent for the treatment of myelofibrosis. Momelotinib is a small-molecule inhibitor of JAK1 (Janus kinase 1), JAK2 (Janus kinase 2) and ACVR1 (Activin A receptor type 1), under development for treatment of patients with myelofibrosis. Co. has conducted a review of data from the two Phase 3 trials of momelotinib, versus ruxolitinib and best available therapy, as well as GS-US-352-1672, a Phase 2, open-label, translational biology trial of momelotinib in transfusion-dependent subjects with myelofibrosis. We show 25 historical shares outstanding datapoints in our SRRA shares outstanding history coverage, used to compute SRRA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SRRA market cap history over the course of time is important for investors interested in comparing SRRA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SRRA versus a peer is one thing; comparing SRRA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SRRA can fluctuate over the course of history. With this page we aim to empower investors researching SRRA by allowing them to research the SRRA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree SRRA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Sierra Oncology (SRRA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

SRRK Market Cap History
SRTS Market Cap History
SSKN Market Cap History
STAA Market Cap History
STAB Market Cap History
STE Market Cap History
STIM Market Cap History
STML Market Cap History
STOK Market Cap History
STRO Market Cap History
More Healthcare companies »

 

SRRA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.